What is the Longitude Prize?
The Longitude Prize is looking for a team of researchers to invent an affordable, accurate, fast and easy-to-use test for bacterial infections that will allow health professionals worldwide to administer the right antibiotics at the right time. £8 million will be awarded to the winner, to help solve the global problem of antibiotic resistance.
Why are we doing this?
On average, antibiotics add 20 years to each person’s life. The development of antibiotics has been vital to our survival, yet the rise of antimicrobial resistance is threatening to make them ineffective in the future. Point-of-care test kits will allow more targeted use of antibiotics, and an overall reduction in misdiagnosis and prescription. They will form a vital part of the toolkit for stewardship of antibiotics in the future. This will ensure that the antibiotics we have now will be effective for longer and we can continue to control infections during routine and major procedures.
What are we doing?
Currently we are working with and supporting more than 50 competing teams of innovators around the world. We are supporting them with collaboration opportunities, preparing them for market-readiness, profiling, and connecting them with new funding opportunities. The prize is open to new entrants at any point.
Only got a few minutes? Watch this to learn more...
AMR Voices: Stories from the frontlines of antimicrobial resistance during Covid-19
The World Health Organisation...
has declared AMR one of the top 10 global public health threats to humanity
One person a minute...
is estimated to die from AMR globally, every year
One in five antibiotic prescriptions...
are unnecessary, meaning that antibiotics may not work properly in the future
Effectiveness of cancer treatments threatened by rising antibiotic resistance
Director, Global Health
Senior Programme Manager, Global Health Team
Assistant Programme Manager